ArticleJournal of the American Society of Nephrology : JASN2026

Overexpression of Thrombomodulin in Adipose-Derived Mesenchymal Stem Cells Reduces Thrombogenic Risk and Enhances Therapeutic Efficacy.

Yoshiki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.